1
|
The hemostatic system as a modulator of atherosclerosis.
|
N Engl J Med
|
2011
|
2.54
|
2
|
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.
|
Ann Intern Med
|
2011
|
2.28
|
3
|
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.
|
J Clin Invest
|
2008
|
1.59
|
4
|
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation.
|
Crit Care Med
|
2005
|
1.58
|
5
|
Endothelial activation in lacunar stroke subtypes.
|
Stroke
|
2010
|
1.55
|
6
|
Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation.
|
Am J Respir Crit Care Med
|
2007
|
1.54
|
7
|
Infection and inflammation and the coagulation system.
|
Cardiovasc Res
|
2003
|
1.49
|
8
|
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable.
|
J Rheumatol
|
2013
|
1.49
|
9
|
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
|
Arch Intern Med
|
2004
|
1.35
|
10
|
Tissue factor in infection and severe inflammation.
|
Semin Thromb Hemost
|
2006
|
1.20
|
11
|
Is thrombin a key player in the 'coagulation-atherogenesis' maze?
|
Cardiovasc Res
|
2009
|
1.20
|
12
|
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation.
|
Arterioscler Thromb Vasc Biol
|
2009
|
1.15
|
13
|
Early atherosclerosis exhibits an enhanced procoagulant state.
|
Circulation
|
2010
|
1.14
|
14
|
Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease.
|
Atherosclerosis
|
2005
|
1.14
|
15
|
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
|
Crit Care Med
|
2010
|
1.11
|
16
|
Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner.
|
PLoS One
|
2013
|
1.11
|
17
|
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy.
|
AIDS Patient Care STDS
|
2009
|
1.11
|
18
|
Endothelium: interface between coagulation and inflammation.
|
Crit Care Med
|
2002
|
1.06
|
19
|
Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation.
|
Blood
|
2007
|
1.05
|
20
|
Infections and endothelial cells.
|
Cardiovasc Res
|
2003
|
1.05
|
21
|
Disseminated intravascular coagulation.
|
Hematol J
|
2003
|
1.05
|
22
|
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.
|
Haematologica
|
2009
|
1.03
|
23
|
Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study.
|
J Clin Periodontol
|
2007
|
1.02
|
24
|
Thrombin generation in patients after acute deep-vein thrombosis.
|
Thromb Haemost
|
2008
|
1.02
|
25
|
The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded.
|
Thromb Haemost
|
2011
|
1.01
|
26
|
Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury.
|
Blood
|
2011
|
1.00
|
27
|
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals.
|
Thromb Haemost
|
2010
|
1.00
|
28
|
Effects of ambient air pollution on hemostasis and inflammation.
|
Environ Health Perspect
|
2009
|
0.99
|
29
|
PTX3 predicts severe disease in febrile patients at the emergency department.
|
J Infect
|
2009
|
0.96
|
30
|
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.
|
PLoS One
|
2012
|
0.96
|
31
|
Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
|
Thromb Haemost
|
2009
|
0.94
|
32
|
Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis.
|
JACC Cardiovasc Imaging
|
2012
|
0.94
|
33
|
The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus.
|
Blood Coagul Fibrinolysis
|
2007
|
0.94
|
34
|
Thrombin generation and atherosclerosis.
|
J Thromb Thrombolysis
|
2014
|
0.93
|
35
|
Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity.
|
Nephrol Dial Transplant
|
2011
|
0.93
|
36
|
Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
|
Transfusion
|
2008
|
0.92
|
37
|
The blood coagulation system as a molecular machine.
|
Bioessays
|
2003
|
0.92
|
38
|
Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation.
|
J Am Coll Cardiol
|
2015
|
0.92
|
39
|
Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory.
|
Thromb Haemost
|
2008
|
0.90
|
40
|
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.
|
Blood Rev
|
2013
|
0.89
|
41
|
Body composition as determinant of thrombin generation in plasma: the Hoorn study.
|
Arterioscler Thromb Vasc Biol
|
2010
|
0.89
|
42
|
Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.
|
Haematologica
|
2012
|
0.89
|
43
|
Prescription of physical activity is not sufficient to change sedentary behavior and improve glycemic control in type 2 diabetes patients.
|
Diabetes Res Clin Pract
|
2010
|
0.88
|
44
|
Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes.
|
Thromb J
|
2005
|
0.88
|
45
|
Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia.
|
Thromb Haemost
|
2011
|
0.87
|
46
|
Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction.
|
Thromb J
|
2006
|
0.86
|
47
|
New insights into modulation of thrombin formation.
|
Curr Atheroscler Rep
|
2013
|
0.86
|
48
|
Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
|
Cardiovasc Res
|
2005
|
0.86
|
49
|
Plasma viscosity and mean platelet volume in patients undergoing coronary angiography.
|
Clin Hemorheol Microcirc
|
2010
|
0.86
|
50
|
The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.
|
Hypertension
|
2005
|
0.86
|
51
|
A pilot study into measurements of markers of atherosclerosis in periodontitis.
|
J Periodontol
|
2005
|
0.85
|
52
|
Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis.
|
Basic Res Cardiol
|
2003
|
0.85
|
53
|
Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling.
|
J Clin Invest
|
2008
|
0.85
|
54
|
The endothelium in intensive care.
|
Crit Care Clin
|
2005
|
0.85
|
55
|
More fibrosis and thrombotic complications but similar expression patterns of markers for coagulation and inflammation in symptomatic plaques from DM2 patients.
|
J Histochem Cytochem
|
2004
|
0.84
|
56
|
The structure-function relationship of activated protein C. Lessons from natural and engineered mutations.
|
Thromb Haemost
|
2011
|
0.84
|
57
|
Signal transduction induced by activated protein C: no role in protection against sepsis?
|
Trends Mol Med
|
2006
|
0.84
|
58
|
Cardiovascular risk in patients with hemophilia.
|
Blood
|
2014
|
0.83
|
59
|
Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited.
|
Thromb Haemost
|
2006
|
0.82
|
60
|
Coagulation on endothelial cells: the underexposed part of Virchow's Triad.
|
Thromb Haemost
|
2012
|
0.82
|
61
|
ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
|
Thromb Res
|
2013
|
0.82
|
62
|
Thrombin generation in the Glasgow Myocardial Infarction Study.
|
PLoS One
|
2013
|
0.82
|
63
|
N-acetylcysteine reduces oxidative stress in sickle cell patients.
|
Ann Hematol
|
2012
|
0.82
|
64
|
Modified two-step model for studying the inflammatory response during myocardial ischemia and reperfusion in mice.
|
Comp Med
|
2003
|
0.81
|
65
|
Lung inflammation and thrombogenic responses in a time course study of Csb mice exposed to ozone.
|
J Appl Toxicol
|
2008
|
0.81
|
66
|
D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review.
|
Thromb Haemost
|
2013
|
0.81
|
67
|
Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article.
|
J Cardiothorac Surg
|
2013
|
0.80
|
68
|
A systematic review of model-based economic evaluations of diagnostic and therapeutic strategies for lower extremity artery disease.
|
Thromb Haemost
|
2013
|
0.80
|
69
|
The technique of measuring thrombin generation with fluorogenic substrates: 1. Necessity of adequate calibration.
|
Thromb Haemost
|
2008
|
0.80
|
70
|
Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.
|
J Hypertens
|
2009
|
0.79
|
71
|
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation--the Hoorn Study.
|
Thromb Res
|
2011
|
0.79
|
72
|
The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.
|
Thromb Haemost
|
2011
|
0.79
|
73
|
Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model.
|
Thromb Haemost
|
2015
|
0.78
|
74
|
Activation of the contact system in patients with a first acute myocardial infarction.
|
Thromb Res
|
2013
|
0.78
|
75
|
Anticoagulant therapy in critical organ ischaemia/reperfusion injury.
|
Thromb Haemost
|
2010
|
0.77
|
76
|
Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.
|
Thromb Haemost
|
2015
|
0.77
|
77
|
Consistency of thromboelastometry analysis under scrutiny: results of a systematic evaluation within and between analysers.
|
Thromb Haemost
|
2014
|
0.77
|
78
|
Reply to Faraoni D, Fenger-Eriksen C, Gillard S et al. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study.
|
Paediatr Anaesth
|
2015
|
0.77
|
79
|
Platelet dysfunction in thrombosis patients treated with vitamin K antagonists and recurrent bleeding.
|
PLoS One
|
2013
|
0.76
|
80
|
Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice.
|
Blood Coagul Fibrinolysis
|
2007
|
0.76
|
81
|
High-affinity antibodies in a new immunoassay for plasma tissue factor: reduction in apparent intra-individual variation.
|
Clin Chem Lab Med
|
2005
|
0.76
|
82
|
The effects of pneumatic tube system transport on ROTEM analysis and contact activation assessed by thrombin generation test.
|
Thromb Res
|
2012
|
0.76
|
83
|
Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis.
|
Atherosclerosis
|
2003
|
0.76
|
84
|
Effects of ultrapure hemodialysis and low molecular weight heparin on the endothelial surface layer.
|
Blood Purif
|
2014
|
0.76
|
85
|
Rivaroxaban for thromboprophylaxis.
|
N Engl J Med
|
2008
|
0.75
|
86
|
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
|
Lancet
|
2003
|
0.75
|
87
|
Dabigatran and apolipoprotein B.
|
Heart
|
2015
|
0.75
|
88
|
Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis.
|
Atherosclerosis
|
2002
|
0.75
|
89
|
Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. A systematic review.
|
Thromb Haemost
|
2015
|
0.75
|
90
|
[Better understanding of blood coagulation in vivo].
|
Ned Tijdschr Geneeskd
|
2009
|
0.75
|
91
|
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients.
|
Biomark Med
|
2014
|
0.75
|
92
|
Safety and efficacy of bridging with low molecular weight heparins: a systematic review and partial meta-analysis.
|
Curr Pharm Des
|
2013
|
0.75
|
93
|
Factor XI gene analysis in thrombophilia and factor XI deficiency.
|
J Thromb Haemost
|
2004
|
0.75
|
94
|
[Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
|
Ned Tijdschr Geneeskd
|
2009
|
0.75
|
95
|
Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
|
Ann N Y Acad Sci
|
2009
|
0.75
|
96
|
Long-term strenuous exercise induces a hypercoagulable state through contact activation.
|
Thromb Haemost
|
2014
|
0.75
|